InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Can-Fite BioPharma Ltd.

CANF Clue Score26
Israel Fiscal year ends December CIK 0001536196
$1.90 -5.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.90 +23.38% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.2Operating income−8.7Net income8.3Fiscal year 2017Revenue0.8 +378.2%Operating income−7.2Net income−4.8 −158.6%Fiscal year 2018Revenue3.8 +384.2%Operating income−5.4Net income−6.6Fiscal year 2019Revenue2.0 −46.8%Operating income−12.0Net income−12.6Fiscal year 2020Revenue0.8 −62.5%Operating income−14.1Net income−14.4EPS, diluted−0.04Fiscal year 2021Revenue0.9 +11.8%Operating income−12.8Net income−12.6EPS, diluted−0.03Fiscal year 2022Revenue0.8 −5.0%Operating income−10.1Net income−10.2EPS, diluted−0.01Fiscal year 2023Revenue0.7 −8.3%Operating income−8.2Net income−7.6EPS, diluted−17.92Fiscal year 2024Revenue0.7 −9.3%Operating income−8.1Net income−7.9EPS, diluted−10.86Fiscal year 2025Revenue0.4 −39.9%Operating income−10.0Net income−9.8EPS, diluted−5.97
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.8 3.8 2.0 0.8 0.9 0.8 0.7 0.7 0.4
Growth +378.2% +384.2% −46.8% −62.5% +11.8% −5.0% −8.3% −9.3% −39.9%
Operating income −8.7 −7.2 −5.4 −12.0 −14.1 −12.8 −10.1 −8.2 −8.1 −10.0
Net income 8.3 −4.8 −6.6 −12.6 −14.4 −12.6 −10.2 −7.6 −7.9 −9.8
Growth −158.6%
EPS, diluted n/a n/a n/a n/a −0.04 −0.03 −0.01 −17.92 −10.86 −5.97

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−5,262.4%Net margin5,004.2%Free cash flow margin−5,287.3%Fiscal year 2017Operating margin−910.6%Net margin−613.7%Free cash flow margin−1,138.0%Fiscal year 2018Operating margin−141.7%Net margin−172.0%Free cash flow margin−109.6%Fiscal year 2019Operating margin−590.9%Net margin−621.3%Free cash flow margin−545.6%Fiscal year 2020Operating margin−1,853.1%Net margin−1,892.9%Free cash flow margin−1,584.4%Fiscal year 2021Operating margin−1,505.5%Net margin−1,478.9%Free cash flow margin−1,157.0%Fiscal year 2022Operating margin−1,246.4%Net margin−1,255.9%Free cash flow margin−1,334.6%Fiscal year 2023Operating margin−1,103.0%Net margin−1,027.5%Free cash flow margin−1,136.2%Fiscal year 2024Operating margin−1,206.2%Net margin−1,169.1%Free cash flow margin−1,133.8%Fiscal year 2025Operating margin−2,456.8%Net margin−2,426.7%Free cash flow margin−2,210.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −5,262.4% −910.6% −141.7% −590.9% −1,853.1% −1,505.5% −1,246.4% −1,103.0% −1,206.2% −2,456.8%
Net margin 5,004.2% −613.7% −172.0% −621.3% −1,892.9% −1,478.9% −1,255.9% −1,027.5% −1,169.1% −2,426.7%
Free cash flow margin −5,287.3% −1,138.0% −109.6% −545.6% −1,584.4% −1,157.0% −1,334.6% −1,136.2% −1,133.8% −2,210.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−8.7Capital expenditure−0.0Free cash flow−8.7Fiscal year 2017Operating cash flow−9.0Capital expenditure−0.0Free cash flow−9.0Fiscal year 2018Operating cash flow−4.2Capital expenditure−0.0Free cash flow−4.2Fiscal year 2019Operating cash flow−11.1Capital expenditure−0.0Free cash flow−11.1Fiscal year 2020Operating cash flow−12.1Capital expenditure−0.0Free cash flow−12.1Dividends paid−0.7Fiscal year 2021Operating cash flow−9.9Capital expenditure−0.0Free cash flow−9.9Dividends paid−2.6Fiscal year 2022Operating cash flow−10.8Capital expenditure−0.0Free cash flow−10.8Fiscal year 2023Operating cash flow−8.4Capital expenditure−0.0Free cash flow−8.4Fiscal year 2024Operating cash flow−7.6Capital expenditure−0.0Free cash flow−7.6Fiscal year 2025Operating cash flow−8.9Capital expenditure−0.0Free cash flow−9.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.7 −9.0 −4.2 −11.1 −12.1 −9.9 −10.8 −8.4 −7.6 −8.9
Capital expenditure −0.0 −0.0 −0.0 −0.0 −0.0 −0.0 −0.0 −0.0 −0.0 −0.0
Free cash flow −8.7 −9.0 −4.2 −11.1 −12.1 −9.9 −10.8 −8.4 −7.6 −9.0
Growth
Dividends paid n/a n/a n/a n/a −0.7 −2.6 n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash8.1Shareholders’ equity3.9Fiscal year 2017Cash3.5Shareholders’ equity3.0Fiscal year 2018Cash3.6Shareholders’ equity3.0Fiscal year 2019Cash2.7Shareholders’ equity2.4Fiscal year 2020Cash8.3Shareholders’ equity6.1Fiscal year 2021Cash4.4Shareholders’ equity14.4Fiscal year 2022Cash3.0Shareholders’ equity4.5Fiscal year 2023Cash4.3Shareholders’ equity6.2Fiscal year 2024Cash4.8Shareholders’ equity5.4Fiscal year 2025Cash5.5Shareholders’ equity5.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.1 3.5 3.6 2.7 8.3 4.4 3.0 4.3 4.8 5.5
Shareholders’ equity 3.9 3.0 3.0 2.4 6.1 14.4 4.5 6.2 5.4 5.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.2 0.8 3.8 2.0 0.8 0.9 0.8 0.7 0.7 0.4
Growth +378.2% +384.2% −46.8% −62.5% +11.8% −5.0% −8.3% −9.3% −39.9%
2.7 2.9 3.2 3.1 n/a n/a n/a n/a n/a n/a
−8.7 −7.2 −5.4 −12.0 −14.1 −12.8 −10.1 −8.2 −8.1 −10.0
Growth
−8.4 −4.8 −6.6 −12.6 −14.4 −12.6 −10.2 −7.6 −7.9 −9.8
0.0 0.0 0.0 n/a n/a n/a n/a n/a n/a n/a
8.3 −4.8 −6.6 −12.6 −14.4 −12.6 −10.2 −7.6 −7.9 −9.8
Growth −158.6%
Per share
n/a n/a n/a n/a −0.04 −0.03 −0.01 −17.92 −10.86 −5.97
n/a n/a n/a n/a −0.04 −0.03 −0.01 −17.92 −10.86 −5.97
Growth
27.7 32.5 38.9 85.9 358.4 553.1 815.7 0.4 0.7 1.6
n/a n/a n/a n/a 358.4 553.1 815.7 0.4 0.7 1.6
Growth +54.3% +47.5% −99.9% +70.2% +127.0%

† The diluted share count jumps at 2021 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 11.9% a year over five years.
  • Operating margin is down 603.7 points on five years ago, at -2,456.8%.
  • A net loss in 9 of 10 years on file.